The present disclosure relates to a pharmaceutical solution having an anti-tumor efficacy-enhancing and toxicity-reducing effect, and a pharmaceutical composition comprising the solution as well as a method for using them. The pharmaceutical solution uses deuterium oxide as a solvent.